May-poll dance: Poland’s presidential race
Economist Podcasts
00:00
ZepBound: A New Contender in Weight Loss
This chapter delves into the success of the weight loss drug ZepBound, comparing it to its competitor Vegovie and discussing its dual action mechanism. It also explores advancements in Eli Lilly's oral medications, pricing strategies, and the competitive dynamics within the pharmaceutical market for weight loss drugs.
Transcript
Play full episode
